Invention Grant
- Patent Title: Thieno-pyridine derivatives as MEK inhibitors
-
Application No.: US12839752Application Date: 2010-07-20
-
Publication No.: US08487101B2Publication Date: 2013-07-16
- Inventor: Daniel Christopher Brookings , Martin Clive Hutchings , Barry John Langham
- Applicant: Daniel Christopher Brookings , Martin Clive Hutchings , Barry John Langham
- Applicant Address: BE Brussels
- Assignee: UCB Pharma S.A.
- Current Assignee: UCB Pharma S.A.
- Current Assignee Address: BE Brussels
- Agency: Feldman Gale, P.A.
- Agent Walter C. Frank
- Priority: GB0801082.9 20080121; GB0812563.5 20080709
- Main IPC: C07D495/04
- IPC: C07D495/04
Abstract:
A series of thieno[2,3-b]pyridine derivatives which are substituted in the 2-position by a substituted anilino moiety, being selective inhibitors of human MEK (MAPKK) enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, proliferative (including oncological) and nociceptive conditions.
Public/Granted literature
- US20110021558A1 THIENO-PYRIDINE DERIVATIVES AS MEK INHIBITORS Public/Granted day:2011-01-27
Information query
